Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Serotonin receptor 1A–modulated phosphorylation of glycine receptor α3 controls breathing in mice
Till Manzke, … , Robert J. Harvey, Diethelm W. Richter
Till Manzke, … , Robert J. Harvey, Diethelm W. Richter
Published October 11, 2010
Citation Information: J Clin Invest. 2010;120(11):4118-4128. https://doi.org/10.1172/JCI43029.
View: Text | PDF
Research Article Pulmonology

Serotonin receptor 1A–modulated phosphorylation of glycine receptor α3 controls breathing in mice

  • Text
  • PDF
Abstract

Rhythmic breathing movements originate from a dispersed neuronal network in the medulla and pons. Here, we demonstrate that rhythmic activity of this respiratory network is affected by the phosphorylation status of the inhibitory glycine receptor α3 subtype (GlyRα3), which controls glutamatergic and glycinergic neuronal discharges, subject to serotonergic modulation. Serotonin receptor type 1A–specific (5-HTR1A–specific) modulation directly induced dephosphorylation of GlyRα3 receptors, which augmented inhibitory glycine-activated chloride currents in HEK293 cells coexpressing 5-HTR1A and GlyRα3. The 5-HTR1A–GlyRα3 signaling pathway was distinct from opioid receptor signaling and efficiently counteracted opioid-induced depression of breathing and consequential apnea in mice. Paradoxically, this rescue of breathing originated from enhanced glycinergic synaptic inhibition of glutamatergic and glycinergic neurons and caused disinhibition of their target neurons. Together, these effects changed respiratory phase alternations and ensured rhythmic breathing in vivo. GlyRα3-deficient mice had an irregular respiratory rhythm under baseline conditions, and systemic 5-HTR1A activation failed to remedy opioid-induced respiratory depression in these mice. Delineation of this 5-HTR1A–GlyRα3 signaling pathway offers a mechanistic basis for pharmacological treatment of opioid-induced apnea and other breathing disturbances caused by disorders of inhibitory synaptic transmission, such as hyperekplexia, hypoxia/ischemia, and brainstem infarction.

Authors

Till Manzke, Marcus Niebert, Uwe R. Koch, Alex Caley, Steffen Vogelgesang, Swen Hülsmann, Evgeni Ponimaskin, Ulrike Müller, Trevor G. Smart, Robert J. Harvey, Diethelm W. Richter

×

Figure 3

Altered modulation of the respiratory network in Glra3–/– mice and 5-HTR1A–induced augmentation of GlyRα3 function via PKA in recombinant systems.

Options: View larger image (or click on image) Download as PowerPoint
Altered modulation of the respiratory network in Glra3–/– mice and 5-HTR...
(A) HEK293 cell expressing 5-HTR1A–eGFP. (B) Time stability profile for IGly recorded from cells coexpressing GlyRα3L and 5-HTR1A. Currents were activated by rapid application of glycine (EC20) before and after activation of 5-HTR1A by 5-HT (green arrow), with (white circles) or without (black squares) coapplication of the selective 5-HTR1A inhibitor WAY 100635. All currents were normalized to IGly at 0 minutes (IGly°). Time points at which the currents in C were taken are denoted. (C) Individual IGly activated by glycine, before and after 5-HTR1A activation and before and after coapplication of 5-HT and WAY 100635. (D) HEK293 cell expressing μOR-mCherry. (E and F) Time stability profiles for IGly from cells coexpressing GlyRα3L and μOR, analogous to B and C. (G and H) HEK293 cells expressing 5-HTR1A and GlyRα3 (G) and immunoblot detection (H) of the phosphorylation status of GlyRα3 before and after drug application. Lane 1, negative control; lane 2, before drug application; lanes 3 and 4, GlyRα3 phosphorylation (decreased after selective activation of 5-HTR1A); lane 5, recovery of phosphorylation after 45 minutes. Activation of PKA with Sp-cAMP, a potent and specific activator of cAMP-dependent protein kinases, increased phosphorylation (lane 6), while Rp-cAMP, a cAMP analog and competitive inhibitor of cAMP-dependent protein kinase I and II, decreased phosphorylation (lane 7). (I) Statistics after densitometric measurement (n = 4). *P < 0.05. (J and K) HEK293 cells expressing μOR and GlyRα3 (J) and immunoblot analogous to H (K). Scale bars: 5 μm (A and D); 20 μm (G and J).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts